From August 4th to 5th, the 6th Biomedical Innovation Cooperation Conference and the 2022 China Biomedical Industry Value List Awards Ceremony were held in Suzhou Jinji Lake Kempinski Hotel. The conference lasted for 2 days and carried out 12 special forums, focusing on the most cutting-edge technical information and interpreting the latest industrial policies. Demand releases, poster presentations and other forms of comprehensive links to industry-university-research-funded multi-party spectrum New Biotech were invited to participate in the awards ceremony and won the "Top 10 Most Growing CXO Enterprises" award. Mr. Li Cha, COO of Puxin Biotechnology, was invited to attend the "2022 China Biomedical Industry Value List Awards Ceremony and Invitational Dinner" held at 18:00 on the evening of August 4, 2022 in the State Guest Room on the 2nd floor of Kempinski Hotel, Suzhou Jinji Lake. and accept the award.

This award is judged from multiple dimensions such as competition elements, commercialization elements, value elements, strategic elements, product elements, and team elements, and conducts in-depth evaluations of industries, industries, and companies to form the "2022 China Biomedical Industry Value List".
This is not only an affirmation of the past, but also a constant spur to its future development. In the future, Puxin Biotech will continue to move forward to help the development of the cell drug industry.